Table 2.

Data of patients pathologically diagnosed with gallbladder cancer

Case	Sex	Age	Preoperative diagnosis	Type of operation	pT	pN	pSM	Additional surgery	Adjuvant therapy	Recurrence	RFS (mo)	Outcome
1	F	71	polyp	LCWL	T2	N0	Negative	S4a and S5 segmentectomy with extrahepatic bile duct resection	No	No	62	Alive
2	F	80	polyp	LCWL	T1a	N0	Negative	-	No	No	53	Alive
3	M	79	chronic cholecystitic	LCWL	T3	N1	Negative	S4a and S5 segmentectomy with extrahepatic bile duct resection	No	No	2	Dead
4	F	80	GBC	LCGB	T2	N0	Negative	Extrahepatic bile duct resection	No	No	55	Alive
5	F	80	GBC	LCGB	T1a	N0	Negative	-	No	No	47	Alive
6	F	83	polyp	LCWL	T2	N0	Negative	-	No	No	41	Alive
7	F	61	GBC	LCGB	T2	N1	Negative	-	No	Liver and bone metastases	9	Dead
8	F	85	GBC	LCGB	T1a	N0	Negative	-	No	No	26	Alive
9	F	66	polyp	LCWL	T2	N0	Negative	LCGB with lymphadenectomy	No	No	23	Alive
9	F	66	definite GBC	LCGB	T2	N0	Negative	-	No	No	-	Alive
10	M	83	GBC	LCGB	T2	N0	Negative	-	No	No	15	Alive
11	M	84	polyp	LCWL	T2	N0	Negative	-	No	No	13	Alive
12	F	78	GBC	LCGB	T2	N1	Negative	-	No	No	12	Alive
13	M	50	polyp	LCWL	T1a	N0	Negative	-	No	No	12	Alive
14	F	86	GBC	LCWL	T1a	N0	Negative	-	No	No	8	Alive
15	F	92	polyp	LCWL	T1a	N0	Negative	-	No	No	7	Alive

LCWL: Laparoscopic whole-layer cholecystectomy; LCGB: Laparoscopic gallbladder bed resection; pSM: Pathological surgical margin; RFS: Relapse-free survival; GBC: Gallbladder cancer.